MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Etrasimod

CAS No. : 1206123-37-6

MCE 站：Etrasimod

产品活性：Etrasimod (APD334) 是高效的有选择性和口服活性的S1P₁受体拮抗剂，在CHO细胞中的IC₅₀值为1.88 nM。

研究领域：GPCR/G Protein

作用靶点：LPL Receptor

In Vitro: APD334 is a structurally novel, selective, functional antagonist of S1P₁. In CHO cells expressing HA tagged S1P₁, APD334 is found to have an IC₅₀ value of 1.88 nM. Moderate agonism at human S1P₄ and S1P₅ is observed but is reduced relative to S1P₁, both in terms of potency and efficacy. APD334 is devoid of any agonism or antagonism at human S1P₂ and S1P₃. APD334 achieves good central exposure following oral dosing and possesses a favorable pharmacokinetic profile in multiple preclinical species. S1P₁ activity is maintained in mice (EC₅₀=0.44 nM), rats (EC₅₀=0.32 nM), dogs (EC₅₀=0.34 nM) and monkeys (EC₅₀=0.32 nM).

In Vivo: APD334 has a relatively low systemic clearance (<4% of hepatic blood flow) and high C_max across all species. In both dog and monkey a significant decrease in volume of distribution (Vss) is observed relative to rodent. Oral bioavailability is in the range of 40–100%, and the terminal phase half-life varied from 6 h in monkey, to as long as 29 h in dog. Rat and monkey t_1/2 values for siponimod (another S1P1 modulator currently in human trials) have been disclosed and are 6 and 19 h, respectively.

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Immunology/Inflammation Compound Library  |  Clinical Compound Library  |  Drug Repurposing Compound Library  |  Orally Active Compound Library  |  Fingolimod hydrochloride  |  PF-543 Citrate  |  Ki16425  |  JTE-013  |  TY-52156  |  AM095  |  Sphingosine-1-phosphate  |  FTY720 (S)-Phosphate  |  SEW?2871  |  LPA2 antagonist 1  |  CYM-5541  |  ONO-7300243  |  1-Oleoyl lysophosphatidic acid  |  AS2717638  |  CYM50308  |  Radioprotectin-1  |  Ceranib-2  |  LPA2 antagonist 2  |  S1P1 Agonist III  |  CYM50260  |  4-Deoxypyridoxine 5'-phosphate  |  GRI977143  |  H2L 5765834  |  Ki16198  |  NSC12404  |  PF-543 hydrochloride  |  S1PR1-MO-1

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。